MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
9.22
+0.58 (6.71%)
At close: Apr 1, 2025, 4:00 PM
9.04
-0.18 (-1.99%)
After-hours: Apr 1, 2025, 7:56 PM EDT

MiNK Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-10.78-22.46-27.99-30.21-16.24
Upgrade
Depreciation & Amortization
0.220.20.120.080.06
Upgrade
Loss (Gain) From Sale of Assets
-0.19----
Upgrade
Stock-Based Compensation
1.813.863.031.740.09
Upgrade
Other Operating Activities
-1.07-0.27-2.7911.836.28
Upgrade
Change in Accounts Payable
-1.18-1.922.66-0.150.61
Upgrade
Change in Unearned Revenue
-----0.19
Upgrade
Change in Other Net Operating Assets
1.644.816.113.891.06
Upgrade
Operating Cash Flow
-9.56-15.76-18.87-12.83-8.34
Upgrade
Capital Expenditures
--0.07-0.25-0.25-0.1
Upgrade
Investing Cash Flow
--0.07-0.25-0.25-0.1
Upgrade
Long-Term Debt Issued
5--9.4611.11
Upgrade
Net Debt Issued (Repaid)
5--9.4611.11
Upgrade
Issuance of Common Stock
5.820.070460
Upgrade
Repurchase of Common Stock
--0.48-0.16--
Upgrade
Other Financing Activities
----6.2-
Upgrade
Financing Cash Flow
10.82-0.41-0.1649.2611.11
Upgrade
Foreign Exchange Rate Adjustments
-0.05-0.030.020.02-0.28
Upgrade
Net Cash Flow
1.21-16.27-19.2536.22.39
Upgrade
Free Cash Flow
-9.56-15.84-19.12-13.08-8.43
Upgrade
Free Cash Flow Per Share
-2.53-4.61-5.68-5.02-3.50
Upgrade
Cash Interest Paid
0.010.030.01--
Upgrade
Levered Free Cash Flow
-8.62-11.08-20.25-8.67-2.21
Upgrade
Unlevered Free Cash Flow
-8.62-11.08-20.25-7.15-0.68
Upgrade
Change in Net Working Capital
4.620.743.8-2.9-6.02
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q